ATE477331T1 - Verfahren zum nachweis einer hiv-infektion - Google Patents

Verfahren zum nachweis einer hiv-infektion

Info

Publication number
ATE477331T1
ATE477331T1 AT07756200T AT07756200T ATE477331T1 AT E477331 T1 ATE477331 T1 AT E477331T1 AT 07756200 T AT07756200 T AT 07756200T AT 07756200 T AT07756200 T AT 07756200T AT E477331 T1 ATE477331 T1 AT E477331T1
Authority
AT
Austria
Prior art keywords
hiv infection
detecting hiv
infection
hiv
afd
Prior art date
Application number
AT07756200T
Other languages
English (en)
Inventor
Yuntao Wu
Dongyang Yu
Jeremy Kelly
Rebecca Yoder
Original Assignee
George Mason Intellectual Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Mason Intellectual Prop filed Critical George Mason Intellectual Prop
Application granted granted Critical
Publication of ATE477331T1 publication Critical patent/ATE477331T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
AT07756200T 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion ATE477331T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79774506P 2006-05-05 2006-05-05
US89415007P 2007-03-09 2007-03-09
PCT/US2007/010750 WO2007130523A2 (en) 2006-05-05 2007-05-04 Compositions and methods for detecting and treating hiv infection

Publications (1)

Publication Number Publication Date
ATE477331T1 true ATE477331T1 (de) 2010-08-15

Family

ID=38624429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07756200T ATE477331T1 (de) 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion

Country Status (6)

Country Link
US (2) US7662547B2 (de)
EP (2) EP2236620A3 (de)
AT (1) ATE477331T1 (de)
CA (1) CA2651317A1 (de)
DE (1) DE602007008398D1 (de)
WO (1) WO2007130523A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ590372A (en) 2008-07-08 2012-09-28 Univ Texas Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats)
US8450337B2 (en) 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
CA2744498C (en) 2008-11-25 2017-10-24 University Of Rochester Mlk inhibitors and methods of use
US20130109687A1 (en) * 2010-04-30 2013-05-02 Gary J. Nabel Methods of treating hiv infection: inhibition of dna dependent protein kinase
US20150104442A1 (en) * 2011-08-15 2015-04-16 King's College London Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence
US10821111B2 (en) 2011-11-30 2020-11-03 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
EP2925319B1 (de) * 2012-11-30 2019-01-09 University Of Rochester Mixed-lineage-kinaseinhibitoren für hiv/aids-therapien
TWI629720B (zh) * 2015-09-30 2018-07-11 Tokyo Electron Limited 用於濕蝕刻製程之溫度的動態控制之方法及設備
CN106074567A (zh) * 2016-07-05 2016-11-09 湖北医药学院 葫芦素b在制备蛋白磷酸酶2a癌性抑制因子抑制剂中的应用
EP3570824A4 (de) * 2017-01-17 2020-10-07 Bar-Ilan University Zusammensetzungen und verfahren zur kontrolle der aktivierung und funktion von natürlichen killerzellen
US12259388B2 (en) * 2018-01-23 2025-03-25 Virongy L.L.C. Cofilin phosphorylation for quantifying CD4 T cell damage and predict CD4 T cell recovery from anti-retroviral therapy
CN110194793B (zh) * 2018-02-26 2020-12-01 中国科学院武汉病毒研究所 一种抑制肌动蛋白重组的多肽及应用
CN118389605A (zh) * 2023-11-13 2024-07-26 艾斯克纳公司 利用多肽增强脂质纳米粒子细胞转染的化合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932221A (en) * 1997-10-30 1999-08-03 Day; Charles E. Genistin-enriched fraction from soy meal
US7052676B2 (en) * 2000-09-26 2006-05-30 The Regents Of The University Of Michigan Methods for inhibition of HIV replication using a small molecule inhibitor
CN1100564C (zh) 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
PL2218342T3 (pl) * 2003-05-27 2019-01-31 Dsm Ip Assets B.V. Nowe kompozycje nutraceutyczne i ich zastosowanie
EP1542016A1 (de) * 2003-12-11 2005-06-15 Institut Gustave Roussy PUMA, phosphoryliertes p53 und p38 MAPK als Marker für HIV-induzierte Apoptose in zirkulierenden T-Zellen eines infizierten Patienten
WO2005103654A2 (fr) * 2004-04-09 2005-11-03 Bioalliance Pharma Methode d’identification de composes actifs sur la replication du virus hiv.

Also Published As

Publication number Publication date
US7662547B2 (en) 2010-02-16
DE602007008398D1 (de) 2010-09-23
CA2651317A1 (en) 2007-11-15
WO2007130523A2 (en) 2007-11-15
EP2236620A2 (de) 2010-10-06
EP2236620A3 (de) 2011-05-25
WO2007130523A3 (en) 2008-06-19
EP2021496B1 (de) 2010-08-11
EP2021496A2 (de) 2009-02-11
US20100292181A1 (en) 2010-11-18
US20080064026A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
ATE477331T1 (de) Verfahren zum nachweis einer hiv-infektion
ATE531820T1 (de) Gesundheitszustandstest
ATE499602T1 (de) Signalprozessierungsschaltkreis mit ionensensitivem feldeffekttransistor sowie verfahren zur überwachung einer eigenschaft einer flüssigkeit
CO6592052A2 (es) Conjugados de polímeros zwiteriónicos multifuncionales
ATE554978T1 (de) Überwachungseinrichtung zur überwachung von systemen eines fahrzeugs
BRPI0923772A2 (pt) artigos absorventes com indicadores visuais de saturação e áreas de marcação primárias e secundárias.
ATE537098T1 (de) System und verfahren zur erfassung der position einer aufzugskabine
ATE540002T1 (de) Vorrichtung zur reinigung von flüssigkeiten, insbesondere zur reinigung von ballastwasser
ATE467689T1 (de) Erkennung der verbindung einer dna-rekombination
ATE498134T1 (de) Nachweis von staphylococcus
EP4308460C0 (de) System zur erfassung des weges von sich bewegenden objekten
EP1933156A4 (de) Vorrichtung zur detektion von nullstrom
EP3734253C0 (de) Vorrichtung zur detektion der elution von proben
ATE551605T1 (de) Verfahren und vorrichtungen zur erkennung von biofilmen
EP3965656A4 (de) Implantierbare vorrichtung zur erfassung von biologischen signalen
DE602005021866D1 (de) Vorrichtung zur verhinderung einer lateralen verschiebung für stabilisatoren
ATE446572T1 (de) Verfahren und system zur bereitstellung eines tonsignals mit erweiterter bandbreite
EP3847459C0 (de) Systeme, sensoren und verfahren zur bestimmung einer konzentration eines analyten
EP3810789C0 (de) Bio-elektrochemischer sensor, system und verfahren zur optimierung der leistung eines abwasserbehandlungssystems
ATE528650T1 (de) Verfahren zum nachweis und zur diagnose einer infektion mit trypanosoma cruzi
EP4097460C0 (de) System zur detektion von analyten
EP1883251A4 (de) Vorrichtung zur detektion von anomalien
DE602005018474D1 (de) Nachweis von hiv-typen und hiv-subtypen
EP3946047A4 (de) Vorrichtung zur erfassung biologischer proben
EP4004429C0 (de) Vorrichtung zur detektion von flüssigkeiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties